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Mice lacking b-adrenoceptors, which mediate the thermogenic effects of norepinephrine and epinephrine, show diminished
thermogenesis and high susceptibility to obesity, whereas mice lacking stearoyl-CoA desaturase 1 (SCD1), which catalyzes the
synthesis of monounsaturated fatty acids, show enhanced thermogenesis and high resistance to obesity. In testing whether
b-adrenergic control of thermogenesis might be mediated via repression of the SCD1 gene, we found that in mice lacking
b-adrenoceptors, the gene expression of SCD1 is elevated in liver, skeletal muscle and white adipose tissue. In none of these
tissues/organs, however, could a link be found between increased sympathetic nervous system activity and diminished SCD1
gene expression when thermogenesis is increased in response to diet or cold, nor is the SCD1 transcript repressed by the
administration of epinephrine. Taken together, these studies suggest that the elevated SCD1 transcript in tissues of mice lacking
b-adrenoceptors is not a direct effect of blunted b-adrenergic signalling, and that b-adrenergic control of SCD1 repression is
unlikely to be a primary effector mechanism in sympathoadrenal regulation of thermogenesis. Whether approaches that target
both SCD1 and molecular effectors of thermogenesis under b-adrenergic control might be more effective than targeting SCD1
alone are potential avenues for future research in obesity management.
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The sympathoadrenal system, through the release of nor-
epinephrine from sympathetic nerves innervating peripheral
tissues and through circulatory epinephrine released by
adrenal medulla, plays an important role in the regulation
of mammalian heat production.1,2 Whereas in large mam-
mals, the sites and molecular mechanisms underlying
adrenergic control of heat production are poorly understood,
studies in small rodents have implicated an elevation in
sympathetic nervous system (SNS) activity in brown adipose
tissue (BAT) – via b-adrenoceptor activation of its uncoupling
protein (UCP1) – as a common mechanism for the stimula-
tion of thermogenesis in response to both dietary and cold
stimuli.3,4 This contention is supported by the demonstra-
tions that both SNS activity and UCP1 are elevated in BAT
from rats and mice exhibiting adaptive increases in thermo-
genesis in response to cold or to overfeeding, and conversely
they are both diminished in BAT from animals showing
adaptive suppression of thermogenesis in response to fasting
or severe food restriction. A major role for the SNS–BAT–
UCP1 axis in thermoregulatory thermogenesis is further
supported by the demonstration that mice lacking b-
adrenoceptors (i.e. b-less mice) and mice deficient in UCP1
show impaired thermogenesis and poor tolerance to cold
exposure.5–7 However, the findings that only the b-less mice,
but not the UCP1-deficient mice, are highly susceptible to
develop obesity have also underscored the existence, even in
small rodents, of mechanisms other than the SNS–BAT–
UCP1 axis in b-adrenergic control of thermogenesis.
In the search for insights into these UCP1-independent
thermogenic mechanisms under b-adrenergic control, the
repression of stearoyl-CoA desaturase 1 (SCD1), a micro-
somal enzyme that catalyzes the synthesis of monounsatu-
rated fatty acids, is of particular significance. Apart from
being components of lipids – that include phospholipids,
triglycerides, cholesterol esters, wax esters and alkyldiacyl-
glycerols – these monounsaturated fatty acids also serve as
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mediators of signal transduction8 that could interfere with
the stimulation of thermogenesis in peripheral tissues.
Indeed, mice lacking SCD1 show an elevated energy
expenditure that confers resistance to obesity9 and that is
associated (in liver and skeletal muscle) with an increase in
the activities of phosphatidylinositol 3-kinase and AMP-
activated protein kinase10–12 – two key signalling pathways
that have been implicated in the orchestration of substrate
flux towards oxidation13 and thermogenesis.14,15 These
findings, together with the demonstrations that (i) SCD1 is
5000 1200
1000
4000
3000
100
800
600
400
200
0 0
Wild-type
β-less
WAT
Skeletal Muscle
Liver
Ch
an
ge
 in
 m
RN
A 
lev
e
ls
(re
lat
ive
 to
 w
ild
-ty
pe
 e
xp
re
ss
ed
 a
s 
10
0%
)
**
**
**
**
*
*
*
Soleus
Heart
BAT
Epididymal
Retroperitoneal
Tibialis anterior
Gastrocnemius
Tensor fascia lata
Figure 1 SCD1 mRNA levels in various organs/tissues of b-less mice compared with wild type controls of same age (7week) and sex (male). All mice originated
from the laboratory of Giacobino6 and fed a standard chow diet. The gene expression analysis was performed by the real-time PCR using iQ SYBR Green Supermix
(BioRad Laboratories, Reinach, Switzerland), the data normalized to the ribosomal protein 36B4, and presented relative to wild-type values expressed as 100%. The
primers utilized for the mouse were as follows: 36B4 – forward 50- TTG TGG GAG CAG ACA ATG TG -30 and reverse 50- AGT CCT CCT TGG TGA ACA CG -30; for the
mouse SCD1 – forward 50- TGG GAA AGT GAG GCG AGC AAC TG -30 and reverse 50- AGG GAG GTG CAG TGA TGG TGG TG -30. All data are mean7s.e. (as vertical
bars) (n¼6), and were analyzed by the Wilcoxon rank sum test for statistically significant differences indicated as follows: *Po0.05 and **Po0.01. BAT: BAT (from
interscapular area); WAT: white adipose tissue.
Table 1 SCD1 mRNA levels in organ/tissues of rats fed ad libitum compared with rats fasted for 3 days, or after 1 week of exposure to cold (41C) compared with
controls at room temperature (221C)
Diet Cold
SNS SCD1 SNS SCD1
Fed Fasted 41C 221C
Liver 115716 0.74**70.13 Liver NS 4.5271.24 106**720
Skeletal muscle Skeletal muscle
Soleus NS 2.8070.4 1.8870.78 Soleus m 27.70710.1 5.73*71.93
Tibialis anterior ? 6.270.95 4.0271.40 Tibialis anterior m 9.9472.3 3.14*70.74
Gastrocnemius NS 1.1470.18 2.1870.49 Gastrocnemius m 5.1971.76 1.45*70.32
Tensor fascia lata ? 0.7870.36 0.8770.52 Tensor fascia lata 2.5770.92 1.8470.6
Heart 2.9670.61 3.1370.82 Heart 3.7271.09 4.3672.74
BAT 11397200 7747126 BAT 429759 3615**7921
WAT WAT
Epididymal NS 3730746 366**712.6 Epididymal 1037071749 646371155
Retroperitoneal NS 62607116 595**721.8 Retroperitoneal 1164072574 710171770
Abbreviations: BAT, brown adipose tissue; NS, clearly not significantly different; SCD1, stearoyl-CoA desaturase 1; SNS, sympathetic nervous system; WAT, white
adipose tissue. Seven-week-old male Sprague–Dawley rats (Elevage-Janvier, France) were caged singly and fed ad libitum on chow diet with access to tap water,
except while fasting they were given a hypotonic saline solution (50mM) to drink. The gene expression analysis was performed by real-time PCR using iQ SYBR Green
Supermix (BioRad), with the following primers: cyclophilin forward 50-TCA GGG CTC TTG AAG TCC C-30 and reverse 50-CAG AAA ATC ACA GCA GCC AAC-30; for rat
SCD1 forward 50-TGG GAA AGT GAA GCG AGC AAC CG-30 and reverse 50-AGA GGG GCA CCT TCT TCA TCT TCT C-30. All data are mean7s.e. (n¼ 6), and were
analyzed by Wilcoxon rank sum test for statistically significant differences indicated as follows: *Po0.05, **Po0.01. The arrows indicate changes in sympathetic
nervous system (SNS) activity in specific organs/tissues in response to diet or cold, as reported in literature.1,18–20 The thick arrows indicate significant increases,
whereas thin arrows indicate tendency to increase but failed to reach statistical significance; NS¼ clearly not significantly different. The symbol ‘?’ indicates ‘data not
available’.
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markedly repressed by leptin,9 a hormone that stimulates
fatty acid oxidation and thermogenesis in peripheral tissues
in part through central activation of sympathetic out-
flow,13,16 and that (ii) impaired thermogenesis in leptin-
deficient (ob/ob) mice can be associated with both an
elevation in hepatic SCD19 and diminished urinary epi-
nephrine,17 underscore a potential link between b-adrenergic
control of SCD1 repression and thermogenesis.
To test the hypothesis that the repression of SCD1 is under
b-adrenergic control, we first investigated whether the gene
expression of SCD1 is increased in the absence of b-
adrenoceptors by comparing its mRNA levels in various
organs and tissues of b-less mice and their wild-type controls.
As shown in Figure 1, SCD1 mRNA levels are markedly
higher in liver (þ36 fold), and to a lesser extent in skeletal
muscle (þ threefold to sevenfold) and in white adipose tissue
(WAT) (from twofold to threefold) from b-less mice than
from wild-type controls. By contrast, no significant between-
group differences in SCD1 mRNA levels are observed in heart
or interscapular BAT, two organs/tissues in which SNS
activity in mice is known to vary in parallel to changes in
thermogenesis in response to cold or diet.1,4 To what extent
the association between b-adrenoceptor and SCD1 repression
shown here in murine liver, skeletal muscle and WAT might
also be dissociated or associated with the functional state of
the SNS in response to diet or cold is unknown, as changes in
SNS activity in these tissues have not been reported in mice.
In the rat, however, the application of kinetic techniques to
the assessment of norepinephrine turnover rate in sym-
pathetically innervated organs/tissues has demonstrated
considerable heterogeneity in sympathetic outflow in re-
sponse to diet or cold,1,18–20 as depicted in Table 1. In
particular, SNS activity is higher in liver but not in skeletal
muscle nor in WAT in fed than in fasted state, and in
response to exposure to cold (at 41C), SNS activity tends to be
higher in skeletal muscle and in WAT but not in liver. Using a
similar study design to investigate SCD1 gene expression in
these various organs/tissues, we found no repression of SCD1
gene expression in liver during feeding nor in skeletal muscle
and inWATafter exposure to cold (Table 1). Furthermore, the
lack of difference in the levels of SCD1 mRNA in heart and
BAT in response to feeding, as well as in heart in response to
cold – despite the well-known increases in SNS activity in
these tissues in the rat – is consistent with our data in
Figure 1, suggesting no adrenergic control of SCD1 in these
tissues. In BAT, the association between elevated SNS activity
and repressed SCD1 mRNA levels in the cold contrasts with
the lack of a similar inverse association in response to diet.
Whereas an a-adrenergic control of SCD1 in BAT in response
to cold, but not to diet, could be invoked, the fact that SCD1
gene expression in BAT from b-less mice are not different
from controls argues against a role for an SNS–badrenocep-
tors-axis in the repression of SCD1. Overall, therefore, the
data in Table 1 suggest that sympathetic neural stimulation
of thermogenesis in response to diet or cold is unlikely to be
mediated through repression of SCD1. A role for repressed
SCD1 in the thermogenic actions of circulating epinephrine
is also unlikely because, as shown in Figure 2, the adminis-
tration of epinephrine, at doses known to stimulate
maximally resting metabolic rate in rodents, failed to repress
the levels of the SCD1 transcript in liver, skeletal muscle or in
WAT, despite evidence of efficacy for epinephrine’s action in
these tissues judging from the increases in gene expression of
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFK-
2/FBPase-2), a marker of increased glycolytic rate.21,22
How then might these data above that are inconsistent
with a role for b-adrenergic repression of SCD1 in relation to
sympathoadrenal regulation of thermogenesis be reconciled
with the upregulation of this gene in liver, skeletal muscle
and WAT from b-less mice. One possibility is that the
upregulation of the SCD1 transcript in these mutants is part
of the enhanced machinery for synthesizing triglycerides
consequential to their diminished thermogenesis. Alterna-
tively (or additionally), an elevated SCD1 might be con-
sequential to metabolic disturbances associated with the
development of their excess adiposity, namely hyperinsuli-
nemia, hyperglycemia and/or increased adipokines like
tumor necrosis factor-a, some or all of which have been
reported to increase SCD1 gene expression in liver, skeletal
muscle and WAT.8 In this context, an upregulation of SCD1
gene expression has also been reported in liver,9 WAT23 and
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Figure 2 SCD1 and PFK-2/FBPase-2 mRNA levels in various organs/tissues
from 7week old male Sprague–Dawley rats treated with epinephrine
compared to controls injected with saline. Epinephrine tartrate (300 mg/kg
body weight) or saline were injected subcutaneously on four successive
occasions with 2 h intervals on the same day, and the animals were killed 2 h
after the last injection (i.e. 8 h after the first injection). The gene expression
analysis was performed by real-time PCR, the data normalized to cyclophilin,
and presented relative to saline control values expressed as 100%. The primers
utilized for cyclophilin and for rat SCD1 are as indicated under Table 1, and
that for PFK-2/FBPase-2 as follows: forward 50- TGG CAG GTC GCC GAA TAC
AGC -30 and reverse 50- TTG GTC AGC TTC GGC CCA CAG -30. All data are
mean7s.e. (as vertical bars) (n¼6), and were analyzed by the Wilcoxon rank
sum test for statistically significant differences indicated as follows: *Po0.05,
**Po0.01; wclose to statistical significance (P¼0.08).
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skeletal muscle24 from other animal models of obesity, and
most recently in skeletal muscle from obese humans.25
Whatever the explanation, however, our studies investi-
gating SCD1 gene regulation under physiological settings of
adaptive changes in thermogenesis in response to diet or to
cold argue against a primary role for SCD1 in the effector
mechanisms by which the sympathoadrenal system regu-
lates adaptive thermogenesis. Whether, from a therapeutic
standpoint, approaches that target both SCD1 and molecular
effectors of thermogenesis under b-adrenergic control might
be more effective than targeting SCD1 alone are potential
avenues for future research in obesity management.
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